<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>95(14)</volume><submitter>Chen JH</submitter><pubmed_abstract>For locally advanced head and neck squamous cell carcinoma (HNSCC), therapeutic decisions depend on comorbidity or age. We estimated the treatment outcomes of patients with different Charlson comorbidity index (CCI) scores and ages to determine whether aggressive treatment improves survival.Data from the Taiwan National Health Insurance and cancer registry databases were analyzed, and we included >20-year-old patients with American Joint Committee on Cancer (AJCC) stage III or IV HNSCC (International Classification of Diseases, Ninth Revision, Clinical Modification codes 140.0-148.9) undergoing surgery, chemotherapy (CT), radiotherapy (RT), concurrent chemoradiotherapy (CCRT), sequential CT and RT, or surgery with adjuvant treatment. The exclusion criteria were a past cancer history, dista</pubmed_abstract><journal>Medicine</journal><pagination>e3268</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4998798</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.</pubmed_title><pmcid>PMC4998798</pmcid><pubmed_authors>Lai MT</pubmed_authors><pubmed_authors>Yen YC</pubmed_authors><pubmed_authors>Chen JH</pubmed_authors><pubmed_authors>Lin KC</pubmed_authors><pubmed_authors>Chang CL</pubmed_authors><pubmed_authors>Yuan SP</pubmed_authors><pubmed_authors>Liu SH</pubmed_authors><pubmed_authors>Chen TM</pubmed_authors><pubmed_authors>Lee FP</pubmed_authors><pubmed_authors>Yang HC</pubmed_authors><pubmed_authors>Wu SY</pubmed_authors><pubmed_authors>Chow JM</pubmed_authors><pubmed_authors>Wu LL</pubmed_authors><pubmed_authors>Wu CC</pubmed_authors><pubmed_authors>Ding YF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.</name><description>For locally advanced head and neck squamous cell carcinoma (HNSCC), therapeutic decisions depend on comorbidity or age. We estimated the treatment outcomes of patients with different Charlson comorbidity index (CCI) scores and ages to determine whether aggressive treatment improves survival.Data from the Taiwan National Health Insurance and cancer registry databases were analyzed, and we included >20-year-old patients with American Joint Committee on Cancer (AJCC) stage III or IV HNSCC (International Classification of Diseases, Ninth Revision, Clinical Modification codes 140.0-148.9) undergoing surgery, chemotherapy (CT), radiotherapy (RT), concurrent chemoradiotherapy (CCRT), sequential CT and RT, or surgery with adjuvant treatment. The exclusion criteria were a past cancer history, dista</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-04T21:50:38.968Z</modification><creation>2019-03-27T02:22:41Z</creation></dates><accession>S-EPMC4998798</accession><cross_references><pubmed>27057882</pubmed><doi>10.1097/MD.0000000000003268</doi></cross_references></HashMap>